Essential regional control of skin cancers
18 May 2017
Essential regional control of skin cancers
Update in anti-CTLA4 and anti-PD1 treatment in advanced melanoma
Novel high risk genes of melanoma
New insights in Merkel cell biology and treatment
Duration of checkpoint inhibitor therapy
PD1/ CTLA4 : Upfront or sequentially?
Deregulated TGF-β superfamily signalling in cancer
Functions of BRCA1 and the implications for treatment
Genetic determinants of breast cancer immune phenotypes
IMPAKT conference highlights
Resistance to CDK4/6 inhibitors
Deciphering the connection of genetics, immune infiltration and prognosis